Contents

Issue 104 • March 2021

In association with

Skinny labelling hits a snag

'Carve outs' and skinny labelling tactics could be on the way out as lawsuits claim generics manufacturers are breaking patents

IN DEPTH

The legacy of Henriette Lacks

Comment

Medical cannabis in Europe

Briefing

Industry news

Pharma industry briefing

Covid-19 briefing

Comment

The pharma deals outlook in 2021

Market access of orphan designated therapies

AI-driven natural drug discovery 

In Depth

HeLa: the legacy of Henrietta Lacks

The history of antibody-drug conjugates 

Premenopausal breast cancer research

Treating the GI symptoms of Covid-19

Tackling akinetic mutism

In Data

Inside the deal

Deals analysis

Market data

02/23/2024 23:26:15
  • Home | Getting the skinny on generics labelling
  • In this issue
  • Contents
  • HOF Sonderanlagenbau Company Insight
  • HOF Sonderanlagenbau
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Mimotopes Company Insight
  • Mimotopes
  • The Solubility company
  • The Solubility Company Insight
  • Comment
  • Market access of orphan designated therapies at risk
  • Lodo Therapeutics’ AI-driven natural drug discovery platform
  • Concert Pharmaceuticals discontinues schizophrenia drug after trial failure
  • Medical cannabis in Europe: a compelling opportunity
  • Exploring the pharma deals outlook in 2021
  • In Depth
  • Skinny labelling of generics: the beginning of the end for this practice?
  • Charting the choppy history of ‘magic bullet’ antibody-drug conjugates
  • How a sleeping drug awakened a patient with akinetic mutism
  • Breast cancer research: addressing the pre-menopausal problem
  • Beyond the lung: treating the GI symptoms of Covid-19
  • Immortal cells and informed consent: the legacy of Henrietta Lacks
  • How radiopharmaceuticals are helping fight cancer with Fusion
  • Competition heats up as new HIV prevention drug shows promise
  • Baxter
  • ACG Worldwide
  • In Data
  • Inside the deal
  • Deals analysis
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
02/17/2021 00:00:00